Publication:
Stimulus properties of venlafaxine in a conditioned taste aversion procedure

dc.contributor.authorKayır, Hakan
dc.contributor.authorAlıcı, Tevfik
dc.contributor.authorYıldırım, Murat
dc.contributor.authorUlusoy, Kemal Gökhan
dc.contributor.authorCeyhan, Mert
dc.contributor.authorÇelik, Turgay
dc.contributor.authorUzbay, Tayfun
dc.contributor.buuauthorGöktalay, Gökhan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFarmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
dc.contributor.orcid0000-0001-6261-4233
dc.contributor.researcheridAAH-1448-2021
dc.contributor.scopusid6508023759
dc.date.accessioned2022-03-21T11:12:08Z
dc.date.available2022-03-21T11:12:08Z
dc.date.issued2008-10-31
dc.description.abstractConditioned stimulus properties of venlafaxine are still unknown. In the present study, the discriminative stimulus properties of venlafaxine by using a conditioned taste aversion procedure were investigated. Swiss Webster mice were allowed to reach water from 2 pipettes for 20 min (09:00-11:30 h), plus 30 min (15:3016:00 h), daily. During the 4 days, the test drugs [fluoxetine, escitalopram, tianeptine, reboxetine, and N omega-nitro-L-arginine methyl ester(L-NAME)l were injected to mice at least 1 h after they had first water session. On day 5, they consumed glucose solution(5%w/v) and immediately injected with conditioning drug (venlafaxine 32 mg/kg). On day 8, mice were allowed to make a choice between water and glucose solution. The amount of glucose consumption as a percentage of total fluid intakes was calculated for each animal. Significant reduction in glucose choice was defined as conditioned taste aversion. Venlafaxine (32 mg/kg) induced a robust conditioned taste aversion in mice. Pre-exposure to tianeptine (2.5-10 mg/kg), fluoxetine (10 mg/kg), escitalopram (32 mg/kg), and reboxetine (5 mg/kg) substituted for venlafaxine by preventing the conditioned taste aversion induced by venlafaxine. L-NAME did not substitute for venlafaxine. Substitution of venlafaxine by fluoxetine, tianeptine, escitalopram, and reboxetine provides further evidence that both 5-HT and noradrenaline reuptake inhibition may play an important role in the stimulus effect of venlafaxine.
dc.identifier.citationKayır, H. vd. (2008). "Stimulus properties of venlafaxine in a conditioned taste aversion procedure". European Journal of Pharmacology, 596(1-3), 102-106.
dc.identifier.endpage106
dc.identifier.issn0014-2999
dc.identifier.issn1879-0712
dc.identifier.issue1-3
dc.identifier.pubmed18786528
dc.identifier.scopus2-s2.0-53049098693
dc.identifier.startpage102
dc.identifier.uri10.1016/j.ejphar.2008.08.015
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0014299908008893
dc.identifier.urihttp://hdl.handle.net/11452/25227
dc.identifier.volume596
dc.identifier.wos000260484900015
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalEuropean Journal of Pharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject(Mice)
dc.subjectAntidepressant
dc.subjectConditioned taste aversion
dc.subjectEscitalopram
dc.subjectFluoxetine
dc.subjectI- name
dc.subjectReboxetine
dc.subjectTianeptine
dc.subjectVenlafaxine
dc.subjectSerotonin reuptake inhibitor
dc.subjectDiscriminative stimulus
dc.subjectAntidepressant
dc.subjectCitalopram
dc.subjectDrugs
dc.subjectPharmacology & pharmacy
dc.subject.emtreeEscitalopram
dc.subject.emtreeFluoxetine
dc.subject.emtreeGlucose
dc.subject.emtreeN(g) nitroarginine methyl ester
dc.subject.emtreeNoradrenalin
dc.subject.emtreeReboxetine
dc.subject.emtreeSerotonin
dc.subject.emtreeTianeptine
dc.subject.emtreeVenlafaxine
dc.subject.emtreeAnimal behavior
dc.subject.emtreeAnimal experiment
dc.subject.emtreeArticle
dc.subject.emtreeControlled study
dc.subject.emtreeDose response
dc.subject.emtreeDrug discrimination
dc.subject.emtreeDrug effect
dc.subject.emtreeDrug mechanism
dc.subject.emtreeDrug substitution
dc.subject.emtreeFluid intake
dc.subject.emtreeGlucose intake
dc.subject.emtreeInstrumental conditioning
dc.subject.emtreeMale
dc.subject.emtreeMouse
dc.subject.emtreeNeurotransmitter uptake
dc.subject.emtreeNonhuman
dc.subject.emtreePriority journal
dc.subject.emtreeStimulus response
dc.subject.emtreeSwiss Webster mouse
dc.subject.emtreeTaste aversion
dc.subject.meshAdrenergic uptake inhibitors
dc.subject.meshAnimals
dc.subject.meshAntidepressive agents
dc.subject.meshAvoidance learning
dc.subject.meshConditioning (psychology)
dc.subject.meshCyclohexanols
dc.subject.meshMale
dc.subject.meshMice
dc.subject.meshNG-nitroarginine methyl ester
dc.subject.meshNitric oxide
dc.subject.meshNitric oxide synthase
dc.subject.meshSerotonin uptake inhibitors
dc.subject.meshTaste
dc.subject.scopusPsychedelic Agent; Serotonin 2A Receptor; Lysergide
dc.subject.wosPharmacology & pharmacy
dc.titleStimulus properties of venlafaxine in a conditioned taste aversion procedure
dc.typeArticle
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: